About Breast Cancer
Breast cancer is one of the most common cancers affecting women worldwide, characterized by malignant growths in breast tissue. Understanding your risks, recognizing symptoms, and seeking timely care are key to better outcomes



General Info
General statistics for understanding breast cancer
- Most common cancer in women (1 in 8 risk)
- Men can get it too (1% - 1 in 726 risk)
- Around 15% of women diagnosed have a family history of breast cancer
- Overall decline in death of 44% since 1989
Question 1
Inflammatory breast cancer
Invasive ductal carcinoma (IDC)
Invasive lobular carcinoma
Medullary carcinoma
IDC is the most common invasive type, originating in the milk ducts.
Risk Factors
Evidence-based indicators linked to disease risk
- Age (50+)
- Family history & BRCA genes
- Hormones (early periods - before age 12, late menopause - after 55, HRT)
- Lifestyle (alcohol, obesity, inactivity)
Symptoms
Various signs that may indicate disease presence
- Lump or swelling
- Skin changes (dimpling, redness, itching)
- Nipple changes (inversion, discharge)
- Persistent breast pain and discomfort
Question 2
2D digital mammogram
Chest X-ray
Ultrasound
3D tomosynthesis
3D mammograms can detect small tumors in dense breast tissue more effectively.
Screening
Tests guided by clinical guidelines and risk profile
- Mammogram
- Ultrasound
- Genetic testing if high risk
- Self-exam: know your normal
Treatment
Approaches determined by current guidelines
- Surgery
- Radiation
- Chemotherapy
- Hormone Therapy
- Immunotherapy
- Targeted Therapy
Outlook
Outlook determined by evidence based results
- Localized stage: 5yr survival - 99%
- Regional stage: 5yr survival - 87%
- Distant stage: 5yr survival - 32%
- New cases risen an average 0.6% each year over 2013–2022
- Rate of death declined an average 1.2% each year over 2014–2023
Question 3
People with metastatic (stage IV) breast cancer
People with HER2-positive breast cancer
People with hormone receptor–positive breast cancer
People with triple-negative breast cancer
Even advanced breast cancer has seen survival improvements because of new therapies, especially targeted and systemic treatments